USPTO serial 87586760
A APERIO CLINICAL OUTCOMES WE MAKE IT CLEAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 20, 2019
- Examiner
- DICKSON, RACHAEL
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with A APERIO CLINICAL OUTCOMES WE MAKE IT CLEAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MORRISVILLE, NC
Morrisville, NC
Morrisville, NC
Durham, NC
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devon E. White
Devon E. White WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL SUITE 300RALEIGH, NC 27607United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | [ Contract research organization (CRO) services, namely, conducting clinical trials for others; Contract research organization (CRO) services, namely, [ monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies for others, ] clinical trial project management and quality assurance for others, [ medical writing of investigational drug protocols and clinical study reports for others, ] data management and electronic data capture (EDC) database programming of clinical trial [ and biostatistical analysis ] for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry [ and the medical device and diagnostics industries] ; Providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy for others; Providing quality assurance services in the medical, pharmaceutical, biotechnology [ and medical device ] fields for others | ACTIVE | Jan 18, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by APERIO CLINICAL OUTCOMES LLC
- Other trademarks owned by INNO Clinical Outcomes, LLC
- Other trademarks owned by INNO Clinical Outcomes, LLC
- Other trademarks owned by APERIO CLINICAL OUTCOMES LLC
- Other trademarks in Class 042
- Similar marks named A APERIO CLINICAL OUTCOMES WE MAKE IT CLEAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 10, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 9, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 14, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Aug 20, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 20, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 17, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 25, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 25, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 13, 2019 | IUAF | USE AMENDMENT FILED | — |
| May 13, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 8, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 12, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 10, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 10, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 10, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 26, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 1, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 1, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 11, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 26, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 26, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 26, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 12, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 12, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 20, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 4, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 5, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 31, 2017 | NWAP | NEW APPLICATION ENTERED | — |